Centricity Wealth Management LLC Acquires New Shares in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Centricity Wealth Management LLC bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 560 shares of the company’s stock, valued at approximately $44,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. Blue Trust Inc. increased its holdings in GE HealthCare Technologies by 9.9% in the third quarter. Blue Trust Inc. now owns 2,334 shares of the company’s stock worth $219,000 after buying an additional 210 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of GE HealthCare Technologies by 2.3% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock worth $2,317,000 after purchasing an additional 562 shares during the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 42.5% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,217 shares of the company’s stock valued at $1,240,000 after purchasing an additional 3,941 shares in the last quarter. Signaturefd LLC lifted its stake in shares of GE HealthCare Technologies by 4.0% in the 3rd quarter. Signaturefd LLC now owns 4,524 shares of the company’s stock valued at $425,000 after purchasing an additional 174 shares during the last quarter. Finally, Eastern Bank bought a new stake in GE HealthCare Technologies in the third quarter worth $204,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 1.1 %

Shares of NASDAQ:GEHC opened at $91.09 on Friday. The company has a 50 day moving average of $85.05 and a 200-day moving average of $85.83. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.80. The stock has a market cap of $41.66 billion, a price-to-earnings ratio of 21.04, a P/E/G ratio of 3.20 and a beta of 1.15. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analysts Set New Price Targets

GEHC has been the topic of several recent research reports. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.